When health policy is the problem: A report from the field

Journal of Health Politics, Policy and Law

Volumn 30, Issue 3, 2005, Pages 327-365

  Spitz, Bruce ^a   Abramson, John ^b  

^a Spitz Consulting Group

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH SERVICE; POLITICS; PROBLEM SOLVING; REVIEW;

CERTIFICATE OF NEED; DRUG INDUSTRY; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH SERVICES RESEARCH; LIFE EXPECTANCY; POLICY MAKING; POLITICS; UNITED STATES;

EID: 21444460130     PISSN: 03616878     EISSN: None     Source Type: Journal    
DOI: 10.1215/03616878-30-3-327     Document Type: Review

References (107)

1. Abramson, J. D. 2004. Overdosed America: The Broken Promise of American Medicine. New York: HarperCollins.
2. Als-Nielsen, Bodil, Wendong Chen, Christian Gluud, and Lise L. Kjaergard. 2003. Association of Funding and Conclusions in Randomized Drug Trials. Journal of the American Medical Association 290: 921-928.
3. Altman, D., Richard Greene, and Harvey M. Sapolsky. 1981. Health Planning and Regulation: The Decision Making Process. Ann Arbor, MI: Association of University Programs in Health Administration.
4. Avorn, J. 2003. Advertising and Prescription Drugs: Promotion, Education, and the Public's Health. Health Affairs Web Exclusive, February 26. www.healthaffairs.org/ WebExclusives/Avorn_Web_Excl_022603.htm.
5. Berkman, N. D., D. A. DeWalt, M. P. Pignone, S. L. Sheridan, K. N. Lohr, L. Lux, S. F. Sutton, et al. 2004. Literacy and Health Outcomes. AHRQ Publication No. 04-E007-2, Rockville, MD: Agency for Healthcare Research and Quality, January.
6. Bero, L. A., and Drummond Rennie. 1996. Influences on the Quality of Published Drug Studies. International Journal of Technological Assessment in Health Care 12:209-237.
7. Board on Health Care Services, Institute of Medicine. 2002. Fostering Rapid Advances in Health Care: Learning, from System Demonstrations. Washington, DC: National Academies Press.
8. Bodenheimer, T. 2000. Uneasy Alliance-Clinical Investigators and the Pharmaceutical Industry. New England Journal of Medicine 342: 1539-1544.
9. Bombardier, Claire, Loren Laine, Alise-Reicin, Deborah Shapiro, Ruben Burgos-Vargas, Barry Davis, Richard Day, Marcos Bosi Ferraz, Christopher J. Hawkey, Marc C. Hochberg, et al. 2000. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis: VIGOR Study Group. New England Journal of Medicine 343: 1520-1528.
10. Centers for Medicare and Medicaid Services. 2000. The CMS Chart Series, An Overview of the US Health Care System: Two Decades of Change, 1980-2000. Baltimore: Centers for Medicare and Medicaid Services.
11. Chollet, D., and L. Achman. 2003. Approaching Universal Coverage: Minnesota's Health Insurance Programs. Publication No. 566. New York: Commonwealth Fund.
12. Collins, S. 2003. On the Edge: Low-Wage Workers and Their Health Insurance Coverage. Publication No. 626. New York: Commonwealth Fund.
13. Committee on the Consequences of Uninsurance, Institute of Medicine. 2002. Care without Coverage: Too Little, Too Late. Washington, DC: National Academies Press.
14. -. 2004. Insuring America's Health: Principles and Recommendations. Washington, DC: National Academies Press.
15. Conover, C., and F. Sloan. 2003. Evaluation of Certificate of Need in Michigan. Vol. 1, Final Report. Durham, NC: Duke University, Center for Health Policy, Law and Management.
16. Council of Economic Advisors. 2002. The Economic Report of the President together with the Annual Report of the Council of Economic Advisors Transmitted to the Congress February 2002. Washington, DC: U.S. Government Printing Office.
17. Cutler, D. M., and M. McClellan. 2001. Is Technological Change in Medicine Worth It? Health Affairs 20: 11-29.
18. Davidoff, F., C. D. DeAngelis, J. M. Drazen, J. Hoey, L. Hojgaard, R. Horton, S. Kotzin, et al. 2001. Sponsorship, Authorship, and Accountability. Journal of the American Medical Association 286: 1232-1234.
19. Davis, K., C. Schoen, C. Schoenbaum, M. Audet, M. Doty, and K. Tenney. 2004. Mirror, Mirror on the Wall: Looking at the Quality of American Health Care through the Patient's Lens. New York: Commonwealth Fund.
20. Department of Justice and Federal Trade Commission. 2004. Improving Health Care: A Dose of Competition. Washington, DC: Department of Justice and Federal Trade Commission.
21. Doshi, J. A., N. Brandt, and B. Stuart. 2004. The Impact of Drug Coverage on COX-2 Inhibitor Use in Medicare. Health Affairs on the Web, February 18. content. healthaffairs.org/cgi/content/abstract/hlthaff.w4.94.
22. Duke University Center for Health Policy, Law and Management, n.d. www.hpolicy .duke.edu/cybereschange/Whatunis.htm (accessed February 21, 2003).
23. Edwards, J. M., M. Doty, and C. Schoen. 2002. The Erosion of Employer-Based Health Coverage and the Threat to Workers' Health Care. Publication No. 559. New York: Commonwealth Fund.
24. Eisenberg, J. M. 1998. Health Services Research in a Market Oriented Health Care System. Health Affairs 17: 98-108.
25. Families USA. 2003. Out-of-Bounds: Rising Prescription Drug Prices for Seniors. www.familiesusa.org/site/DocServer/Out_of_Bounds.pdf?docID=1522.
26. Feldstein, P. 1993. Health Care Economics. Albany, NY: Delmar.
27. Field, M. J., R. E. Tranquada, and J. C. Feasley, eds. 1995. Health Services Research: Work Force and Educational Issues. Washington, DC: National Academies Press.
28. Fisher, Elliott S. 2003. More Medicine Is Not Better Medicine. New York Times, December 1.
29. Fisher, Elliott S., David E. Wennberg, Thérèse A. Stukel, Daniel J. Gottlieb, F. L. Lucas, and Étoile L. Pinder. 2003a. The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care. Annals of Internal Medicine 138: 273-287.
30. Fisher, Elliott S., David E. Wennberg, Thérèse A. Stukel, Daniel J. Gottlieb, F. L. Lucas, and Étoile L. Pinder. 2003b. The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care. Annals of Internal Medicine 138: 288-298.
31. Fortune. 2003a. Fortune Five Hundred: Largest Corporations, F1-F19.
32. - 2003b. Fortune Five Hundred: How the Industries Stack Up, F24-F311.
33. - 2003c. Fortune One Thousand Ranked within Industries, F44-67.
34. Freudenheim, M. 1998. The Media Business: Advertising; Influencing Doctor's Orders. New York Times, November 17. query.nytimes.com/search/
35. Friedman, J., ed. 1996. The Rational Choice Controversy: Economic Models of Politics Reconsidered. New Haven, CT: Yale University Press.
36. Gabel, J., G. Claxton, E. Holve, J. Pickreign, H. Whitmore, K. Dhont, S. Hawkins, and D. Rowlant. 2003. Health Benefits in 2003. Health Affairs 22: 117-126.
37. Glied, S. 2001. Challenges and Options for Increasing the Number of Americans with Health Insurance. Inquiry 38: 90-105.
38. Goldkind, L. 2001. Medical Officer's Gastroenterology Advisory Committee Briefing Document. Celebrex (celecoxib), February 7. www.fda.gov/ohrms/dockets/ ac/01/ briefing/3677b1_05_gi.doc.
39. Goodman, David C., Elliott S. Fisher, George A. Little, Thérèse A. Stukel, Chiang-hua Chang, and Kenneth S. Schoendorf. 2002. The Relation between the Availability of Neonatal Intensive Care and Neonatal Mortality. New England Journal of Medicine 346: 1538-1544.
40. Grantmakers in Health. 2002. About GIH: Funding Partners. www.gih.org/info-url_ nocat2663/info-url_nocat.htm.
41. Greene, T., and S. Harrison. 2002. The Social Health Maintenance Organization Demonstration Project, and V. Wilbur, Public Comment Transcript, Medicare Payment Advisory Commission Public Meeting, Ronald Reagan Building, Washington, DC, September 12, 2002.
42. Gruber, J. 2002. Modeling State Health Insurance Expansions and, Unfortunately, Contractions. Paper presented at the Health Resources Services Administration State Health Planning Grants Conference, Washington, DC, September 24.
43. Hadley, J. 2002. Sicker and Poorer: The Consequences of Being Uninsured. Washington, DC: Kaiser Commission on Medicaid and the Uninsured.
44. Hall, S. S. 2001. Prescription for Profit. New York Times Magazine, March 11, 43.
45. Harrington, A. 2003. Honey, I Shrunk the Profits. Fortune 147: 7, 197-199.
46. HealthGrades. 2004. HealthGrades Quality Study: Patient Safety in American Hospitals. Lakewood, CO: HealthGrades.
47. Hellinger, F. 1976. The Effects of Certificate of Need Legislation on Hospital Investment. Inquiry 13: 187-193.
48. Hibbard, Judith H., Jean Stockard, and Martin Tusler. 2003. Does Publicizing Hospital Performance Stimulate Quality Improvement Efforts? Health Affairs 22: 84-94.
49. Holahan, J., A. Weil, and J. Weiner. 2003. Which Way for Federalism and Health Policy? Health Affairs Web Exclusive, July 16. content.healthaffairs.org/ cgi/reprint/ hlthaff.w3.317vl.
50. Holmer, A. F. 1999. Direct-to-Consumer Prescription Drug Advertising Builds Bridges between Patients and Physicians. Journal of the American Medical Association 281: 380-382.
51. Horton, R. 2001. Lotronex and the FDA: A Fatal Erosion of Integrity. Lancet 357(9268): 1544-1545.
52. Iglehart, J. K. 2000. Revisiting the Canadian Health Care System. New England Journal of Medicine 342: 2007-2012.
53. Jennings, P. 2002. Peter Jennings Reporting: Bitter Medicine. ABC News, May 29.
54. Journal of Health Politics, Policy and Law. 1997. 22(2). Durham, NC: Duke University Press.
55. Kahneman, D., and A. Tversky, eds. 2000. Choices, Values, and Frames. New York: Russell Sage.
56. Kaiser Commission on Medicaid and the Uninsured. 2002. Health Insurance Coverage in America: 2000 Data Update. Washington, DC: Henry J. Kaiser Family Foundation, February.
57. Kass, L. 2002. Life, Liberty, and the Defense of Dignity: The Challenge for Bioethics. San Francisco: Encounter Books.
58. Khan, A., R. M. Leventhal, S. R. Khan, and W. A. Brown. 2002. Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database. Journal of Clinical Psychopharmacology 22: 40-45.
59. Khan, Arif, Heather A. Warner, and Walter A. Brown. 2000. Symptom Reduction and Suicide Risk in Patients Treated with Placebo in Antidepressant Clinical Trials: An Analysis of the Food and Drug Administration Database. Archives of General Psychiatry 57: 311-317.
60. Kleinke, J. D. 2001. The Price of Progress: Prescription Drugs in the Health Care Market. Health Affairs 20(5): 43-60.
61. Knox, R. 1999. Secrecy and Science. Boston Globe, March 30.
62. Kohn, Linda T., Janet M. Corrigan, and Molla S. Donaldson. 1999. To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press.
63. Leutz, W., E. Feldman, L. Nonnenkcamp, B. Hillegas, and S. Irvin. 2000. Innovations in Care for the Elderly: A Congressional Resource Guide on Social HMOs. Waltham, MA: Social HMO Consortium, Schneider Institute for Health Policy.
64. Levit, K., C. Smith, C. Cowan, H. Lazenby, A. Sensenig, and A. Catlin. 2003. Trends in U.S. Health Care Spending, 2001. Health Affairs 22: 154-164.
65. Lindblom, C. E. 1992. Inquiry and Change. New Haven, CT: Yale University Press.
66. Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. 1998. Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels. New England Journal of Medicine 339: 1349-1357.
67. McClellan, M. 2002. The Health Care Crisis: The President's Plan for High-Quality, Affordable Care. Heritage Foundation Lecture, November 5. Washington, DC: Heritage Foundation.
68. McGlynn, Elizabeth A., Steven M. Asch, John Adams, Joan Keesey, Jennifer Hicks, Alison DeCristofaro, and Eve A. Kerr. 2003. The Quality of Care Delivered to Adults in the United States. New England Journal of Medicine 348: 2635-2645.
69. Melander, Hans, Jane Ahlqvist-Rastad, Gertie Meijer, and Björn Beermann. 2003. Evidence B(i)ased Medicine-Selective Reporting from Studies Sponsored by Pharmaceutical Industry: Review of Studies in New Drug Applications. British Medical Journal 326: 1171-1175.
70. Milstein, A., and N. Adler. 2003. Out of Sight, Out of Mind: Why Doesn't Widespread Clinical Failure Command Our Attention? Health Affairs 22(2): 119-127.
71. National Bureau of Economic Research (NBER). 2002. Health Care Report Cards May Fail Patients. www.nber.org/digest/jan02/w8697.html.
72. National Institute for Health Care Management Research and Educational Foundation. 2002. Changing Patterns of Pharmaceutical Innovation, May. www.nihcm .org/innovations.pdf.
73. Organisation for Economic Co-operation and Development (OECD). 2003. Health at a Glance. Paris: Organisation for Economic Co-operation and Development.
74. RAND. 2002. Report Cards for Health Care. RAND Health Research Highlights, RB-4544. www.rand.org/publications/RB/RB4544/.
75. Rosenbaum, S., J. Darnell, P. Keenan, and L. Simon. 1999. Section 115 Waivers: Charting a Path for Medicaid Managed Care Reform. In Access to Health Care: Promises and Prospects for Low-Income Americans, ed. M. Blanton, R. Martinez, B. Lyons, and D. Rowland, 179-198. Washington, DC: Kaiser Commission of Medicaid and the Uninsured.
76. Salkever, D., and T. Bice. 1976. The Impact of Certificate-of-Need Controls on Hospital Investment. Milbank Memorial Fund Quarterly 54: 185-214.
77. Salzberg, S. 1995. Lovingkindness. Boston: Shambala.
78. Schlesinger, M. 2004. Correspondence to Bruce Spitz, March 18.
79. Schneller, E., T. Riley, and J. Rosenthal. 2002. Rising Health Care Costs: State Health Cost Containment Approaches. Portland, ME: National Academy for State Health Policy.
80. Silverstein, Fred E., Gerald Faich, Jay L. Goldstein, Lee S. Simon, Theodore Pincus, Andrew Whelton, Robert Makuch, Glenn Eisen, Naurang M. Agrawal, William F. Stenson, et al. 2000. Gastrointestinal Toxicity with Celecoxib versus Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis, The CLASS Study: A Randomized Controlled Trial. Journal of the American Medical Association 284: 1247-1255.
81. Simon, H. 1997. Models of Bounded Rationality. Vols. 1-3. Boston: MIT Press.
82. Sloan, F., and B. Steinwald. 1980a. Effects of Regulation on Hospital Costs. Journal of Law and Economics 23: 81-109.
83. -. 1980b. Insurance, Regulation, and Hospital Costs. Lexington, MA: Lexington Books.
84. Spitz, B. 2002. The Insurers' Perspective on the Health Care System, Insurance, and the Uninsured. In The New Hampshire State Planning Grant Final Report, June 2. Concord, NH: New Hampshire Department of Health and Human Services.
85. Starfield, B. 2000. Is US Health Care Really the Best in the World? Journal of the American Medical Association 284: 483-485.
86. -. 2003. Correspondence to John Abramson, June 20.
87. Steinwachs, D. 2003. Testimony of the Coalition for Health Services Research to the Subcommittee on Labor, Health and Human Services, Education and Related Agencies, Committee on Appropriations, U.S. House of Representatives, May 7.
88. Stolberg, S., and G. Harris. 2003. Industry Fights to Put Imprint on Drug Bill. New York Times, September 5.
89. Targum, S. L. 2001. S. L. Targum to S. Cook and M. L. Villalba. Consultation NDA 21-042, S-007 Review of Cardiovascular Safety Database. Memorandum, February 1, 21. Rockville, MD: Food and Drug Administration, www.fda.gov/ohrms/ dockets/ac/01/briefing/3677b2_06_cardio.pdf.
90. Thompson, J. W., S. D. Pinidiya, K. W. Ryan, E. D. McKinley, S. Alston, J. E. Bost, J. Briefer French, and P. Simpson. 2003. Health Plan Quality-of-Care Information Is Undermined by Voluntary Reporting. American Journal of Preventive Medicine 24: 62-70.
91. U.S. Department of Education, National Center for Education Statistics, National Adult Literacy Survey. 1992. A First Look at the Findings of the National Adult Literacy Survey, NCES/993-275. Washington, DC: U.S. Government Printing Office.
92. U.S. General Accounting Office. 1995. Medicaid Section 1115 Waivers, GAO/HEHS-96-44, November. Washington, DC: U.S. General Accounting Office.
93. -. 1998. Medical Savings Accounts: Results from Surveys of Insurers. GAO/ HEHS-99-34. Washington, DC: U.S. General Accounting Office, December.
94. -. 2002. Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising Has Limitations. GAO-03-177. Washington, DC: U.S. General Accounting Office, October.
95. Villalba, M. L. 2001. Statistical Reviewer Briefing Document for the Advisory Committee (Rofecoxib). Rockville, MD: U.S. Food and Drug Administration, www.fda .gov/ohrms/dockets/ac/01/briefing3677b2_04_stats.pdf.
96. Watson, N. 2001. Inside the 500: Revenues Rose; Profit Growth Slowed. And, No, Tech on the 500 Didn't Die. Fortune, April 16. www.fortune.com/fortune/ fortune500/ articles/0.15114,369600.htm.
97. Wayne, L., and M. Peterson. 2001. A Muscular Lobby Rolls Up Its Sleeves. New York Times, November 4. www.nytimes.com.
98. Wennberg, J. E., E. S. Fisher, and J. S. Skinner. 2002. Geography and the Debate over Medicare Reform. Health Affair: A Supplement to Health Affairs, Web Exclusives, February 13, 2002, W96-W114. content.healthaffairs.org/cgi/reprint/ hlthaff .W2.96v1.
99. White, J. 1995. Competing Solutions: American Health Care Proposals and International Experience. Washington, DC: Brookings Institution.
100. Wilbur, V. 2002. Public Comment. Medicine Payment Advisory Commission Public Meeting, September 12. Washington, DC: Ronald Reagan Building.
101. Wilkes, Michael S., Robert A. Bell, and Richard L. Kravitz. 2000. Direct-to-Consumer Prescription Drug Advertising: Trends, Impact and Implications. Health Affairs 19(2): 110-128.
102. Wolfe, S. M., L. D. Sasich, A. M. Zieve, and D. C. Vladeck. 2002. Comments to FDA on First Amendment Issues, Specifically Related to FDA Enforcement of Drug Advertising Laws and Regulations. HRG Publication No. 1645. Washington, DC: Public Citizen Health Research Group.
103. Wooldridge, J., R. Brown, L. Foster, S. Hoag, C. Irvin, R. L. Kane, R. Newcomer, B. Schneider, and K. D. Smith. 2001. Social Health Maintenance Organizations: Transition to Medicare + Choice. Princeton, NJ: Mathematica Policy Research.
104. Woolhandler, Steffie, and David U. Himmelstein. 2002. Paying for National Health Insurance-and Not Getting It. Health Affairs 21(4): 88-98.
105. World Health Organization. 2003. World Health Report 2003. Geneva: WHO.
106. Yankelovich, D. 1996. The Debate That Wasn't: The Public and the Clinton Health Care Plan. In The Problem That Won't Go Away: Reforming U.S. Health Care Financing, ed. Henry Aaron, 70-109. Washington, DC: Brookings Institution.
107. Yergin, D., and J. Stanislaw. 1998. The Commanding Heights: The Battle between Government and the Marketplace That Is Remaking the Modern World. New York: Simon and Schuster.